During an inspection of a national medicines regulatory auth…
During an inspection of a national medicines regulatory authority, auditors discover that several regulatory decisions relating to medicine registration were not adequately documented. Supporting scientific evaluations, reviewer comments, approval justifications, and change histories could not be reconstructed. The inspectors conclude that deficiencies in documentation practices have compromised compliance with Good Regulatory Practice. Why is Good Documentation Practice essential within Good Regulatory Practice?
Read DetailsAn applicant receives a dossier for an oral tablet from the…
An applicant receives a dossier for an oral tablet from the Indian manufacturer of the product, for which an application for registration is to be prepared for submission to SAHPRA.The product will have one supplier of the API, and will contain no substances from human or animal origin. A BE study was carried out in support of efficacy, and results of comparative dissolution between the test and reference product is also included.The dossier received does not contain the information in the format required for South Africa in Module 3.2.R Regional Information, but just a folder with documents. Indicate how the information will be included and how module 3.2.R will be structured with the sections required in terms of granularity.
Read DetailsA regulatory affairs officer is preparing an electronic Comm…
A regulatory affairs officer is preparing an electronic Common Technical Document (eCTD) application for submission to the South African Health Products Regulatory Authority (SAHPRA). While reviewing the South African guideline SAHPGL-HPA-09 against the ICH eCTD v3.2.2 specification, the officer notices a difference in the numbering convention for the initial submission sequence. What is the most notable difference between the SAHPRA eCTD specification and the standard ICH eCTD v3.2.2 specification regarding initial sequence numbering?
Read Details